GGrantIndex
← Leaderboards

Peter Buttrick

University Of Illinois At Chicago

$13,327,562
Attributed
$20,284,370
Total exposure
14
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,284,370 · 14

By mechanism

R01$6,848,311 · 4
T32$5,716,243 · 2
P01$2,833,880 · 2
R38$2,225,134 · 1
P20$1,733,448 · 2
S10$505,719 · 1

Most similar at University Of Illinois At Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Cardiovascular System

Research focus

Cardiovascular SystemSiteHeart DiseasesMicrofilamentsHeartCardiacPathologicTroponinComplexResponseHeart FailureLearningDesignProtein Kinase CTissuesCellsAnimal ModelCardiac MyocytesResearch PersonnelProtein IsoformsPreventGenetically Modified AnimalsLaboratory MouseBiopsy

Grant awards (55)

Colorado StARR Program (CSP)$426,349
R38 · FY2025 · HL
Colorado StARR Program (CSP)$426,349
R38 · FY2024 · HL
Colorado StARR Program in Medicine and Pediatrics (CSPMP)$343,109
R38 · FY2023 · HL
Post Graduate Studies in Cardiovascular Research$243,985
T32 · FY2023 · HL · contact PI
Post Graduate Studies in Cardiovascular Research$432,533
T32 · FY2022 · HL · contact PI
Colorado StARR Program in Medicine and Pediatrics (CSPMP)$343,109
R38 · FY2022 · HL
Colorado StARR Program in Medicine and Pediatrics (CSPMP)$343,109
R38 · FY2021 · HL
Post Graduate Studies in Cardiovascular Research$297,188
T32 · FY2021 · HL · contact PI
Colorado StARR Program in Medicine and Pediatrics (CSPMP)$343,109
R38 · FY2020 · HL
Post Graduate Studies in Cardiovascular Research$309,740
T32 · FY2020 · HL · contact PI
Post Graduate Studies in Cardiovascular Research$380,734
T32 · FY2019 · HL · contact PI
Post Graduate Studies in Cardiovascular Research$285,190
T32 · FY2018 · HL · contact PI
Post Graduate Studies in Cardiovascular Research$351,336
T32 · FY2017 · HL · contact PI
Post Graduate Studies in Cardiovascular Research$6,631
T32 · FY2017 · HL · contact PI
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar$687,714
R01 · FY2016 · HL
Post Graduate Studies in Cardiovascular Research$345,362
T32 · FY2016 · HL · contact PI
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar$677,397
R01 · FY2015 · HL
Post Graduate Studies in Cardiovascular Research$334,674
T32 · FY2015 · HL · contact PI
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar$671,793
R01 · FY2014 · HL
Small Animal Ultrasound Imager - Vevo 2100$505,719
S10 · FY2014 · OD · contact PI
Post Graduate Studies in Cardiovascular Research$290,202
T32 · FY2014 · HL · contact PI
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar$650,494
R01 · FY2013 · HL
Post Graduate Studies in Cardiovascular Research$169,367
T32 · FY2013 · HL · contact PI
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar$681,080
R01 · FY2012 · HL
Post Graduate Studies in Cardiovascular Research$330,540
T32 · FY2012 · HL · contact PI
Biochemical Markers of Progressive Heart Disease$191,250
R21 · FY2012 · HL · contact PI
Using Molecular Pathology to Predict Response in Heart Failure$751,000
P20 · FY2011 · HL · contact PI
Biochemical Markers of Progressive Heart Disease$229,500
R21 · FY2011 · HL · contact PI
Post Graduate Studies in Cardiovascular Research$178,440
T32 · FY2011 · HL · contact PI
Using Molecular Pathology to Predict Response in Heart Failure$749,948
P20 · FY2010 · HL
Post Graduate Studies in Cardiovascular Research$301,820
T32 · FY2010 · HL · contact PI
Sarcomeric Modifications and Progressive Cardiac Maladaptation$415,950
P01 · FY2009 · HL · contact PI
Post Graduate Studies in Cardiovascular Research$330,838
T32 · FY2009 · HL · contact PI
Myofilament Function in Human Heart Failure$408,464
R01 · FY2008 · HL · contact PI
Sarcomeric Modifications and Progressive Cardiac Maladaptation$398,623
P01 · FY2008 · HL · contact PI
Myofilament Function in Human Heart Failure$417,035
R01 · FY2007 · HL · contact PI
Sarcomeric Modifications and Progressive Cardiac Maladaptation$407,304
P01 · FY2007 · HL · contact PI
Myofilament Function in Human Heart Failure$479,426
R01 · FY2006 · HL · contact PI
Sarcomeric Modifications and Progressive Cardiac Maladaptation$385,089
P01 · FY2006 · HL · contact PI
PLANNING GRANT FOR INSTITUTIONAL CTSA$232,500
P20 · FY2006 · RR · contact PI
Myofilament Function in Human Heart Failure$479,226
R01 · FY2005 · HL
Sarcomeric Modifications and Progressive Cardiac Maladaptation$383,287
P01 · FY2005 · HL
Training in Cellular Mechanisms of CVD$360,582
T32 · FY2005 · HL
MECHANISM OF DIABETIC CARDIOMYOPATHY$424,890
R01 · FY2004 · HL
Training in Cellular Mechanisms of CVD$380,566
T32 · FY2004 · HL
Phosphorylation of myocardial proteins in diabetic cardiomyopathy$885
M01 · FY2004 · RR
MECHANISM OF DIABETIC CARDIOMYOPATHY$420,379
R01 · FY2003 · HL
Training in Cellular Mechanisms of CVD$386,515
T32 · FY2003 · HL
MECHANISM OF DIABETIC CARDIOMYOPATHY$346,238
R01 · FY2002 · HL
Effect of protein kinase C on cardiac hypertrophy$281,209
P01 · FY2002 · HL
MECHANISM OF DIABETIC CARDIOMYOPATHY$34,232
R01 · FY2002 · HL
MECHANISM OF DIABETIC CARDIOMYOPATHY$345,121
R01 · FY2001 · HL
Effect of protein kinase C on cardiac hypertrophy$281,209
P01 · FY2001 · HL
Effect of protein kinase C on cardiac hypertrophy$281,209
P01 · FY2000 · HL
EFFECTS OF PROTEIN KINASE C ON CARDIAC HYPERTROPHY$124,822
R01 · FY2000 · HL